To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
JMCP Outsert - Non-small Cell Lung Cancer NSCLC (Bridging the Gaps)
FINDINGS FROM THE AMCP MARKET INSIGHTS PROGRAM | July, 2023
Summary
Lung cancer is the most common cancer worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancers. The National Institutes of Health estimated that cancer care cost the US $208.9 billion in 2020, $23.8 billion of which was due to lung cancer. View the full fundings from the program on JMCP.
For more disease state research, view the Market Insights Program.
Related
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - November 2025 Issue
Featured News & Resources
See Full Calendar
Other Events
Award Applications Open
Webinars
AMCP eLearning Day: Nexus Encore
National Meetings
AMCP 2026 Registration Opens
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
